col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


29 Ergebisse       Seite 1

 [1] 
Elsevier: Molecular Therapy — Methods & Clinical Development
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―10 Optimization of Hypo-alloimmunogenic Multispecific CAR-T Cells and SARS-CoV-2-Specific T Cells for Off-the-shelf Adoptive Cell Therapy King Pan Ng, Michaela Su-fern Seng, Wing Leung
2 [GO] 2025―Apr―02 Engineered ACE2 Decoy in Dry Powder Form for Inhalation: A Novel Therapy for SARS-CoV-2 Variants Takaaki Ito, Tatsuya Suzuki, Sakai Yusuke, Keisuke Nishioka, Yumi Itoh, Kentarou Sakamoto, et al. (+7)
3 [GO] 2024―Nov―15 mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting Hareth A. Al-Wassiti, Stewart A. Fabb, Samantha L. Grimley, Ruby Kochappan, Joan K. Ho, Chinn Yi Wong, et al. (+20)
4 [GO] 2024―Okt―30 Off-the-Shelf Allogeneic Natural Killer (NK) Cells for the Treatment of COVID-19 Winnie L. Liu, Eleftheria Kampouri, John K. Bui, Mandeep K. Sekhon, Almudena Tercero, Dan Finlay, et al. (+9)
5 [GO] 2024―Aug―19 Lipid nanoparticle encapsulation improves effectiveness of a Delta Spike-CD40L DNA vaccine against homologous and heterologous SARS-CoV-2 challenge in Syrian hamsters Levi Tamming, Diana Duque, Anh Tran, Casey Lansdell, Grant Frahm, Jianguo Wu, et al. (+20)
6 [GO] 2024―Jan―22 Expanded specific T cells to hypomutated regions of the SARS-CoV-2 using mRNA electroporated antigen presenting cells. Elizabeth Ogando-Rivas, Paul Castillo, Changlin Yang, Vrunda Trivedi, Dingpeng Zhang, Fernanda Pohl-Guimarães, et al. (+6)
7 [GO] 2024―Jan―17 High-titer manufacturing of SARS-CoV-2 spike-pseudotyped VSV in stirred-tank bioreactors Hayley M. Todesco, Chris Gafuik, Cini M. John, Erin L. Roberts, Breanna S. Borys, Alexis Pawluk, et al. (+3)
8 [GO] 2023―Sep―16 A T Cell-Targeted Multi-Antigen Poxvirus Vector Vaccine Generates Robust Cellular and Humoral Immunity Against SARS-CoV-2 Infection Stephen Boulton, Joanna Poutou, Rida Gill, Nouf Alluqmani, Xiaohong He, Ragunath Singaravelu, et al. (+15)
9 [GO] 2023―Jun―28 Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenoviral vectored SARS-CoV-2 vaccine expressing the spike protein Ekramy E. Sayedahmed, Marcelo Valdemir Araújo, Taiana Tainá Silva-Pereira, Shubhada K. Chothe, Ahmed Elkashif, Marwa Alhashimi, et al. (+18)
10 [GO] 2023―Jan―02 A linear DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain elicits potent immune response and neutralizing antibodies in domestic cats Antonella Conforti, Elisa Sanchez, Erika Salvatori, Lucia Lione, Mirco Compagnone, Eleonora Pinto, et al. (+11)
11 [GO] 2022―Okt―06 A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses Klara Lenart, Fredrika Hellgren, Sebastian Ols, Xianglei Yan, Alberto Cagigi, Rodrigo Arcoverde Cerveira, et al. (+8)
12 [GO] 2022―Sep―24 SARS-CoV-2 Infection Increases the Gene Expression Profile for Alzheimer’s Disease Risk Ryan Green, Karthick Mayilsamy, Andrew R. McGill, Taylor Martinez, Bala Chandran, Laura J. Blair, et al. (+3)
13 [GO] 2022―Jul―06 Decrease in Angiotensin Converting Enzyme 2 activity but not concentration in plasma/lungs in COVID-19 patients - offers clues for diagnosis/treatment Henry Daniell, Smruti K. Nair, Yao Shi, Ping Wang, Kathleen T. Montone, Pamela A. Shaw, et al. (+8)
14 [GO] 2022―Jun―22 Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2 Panli Zhang, Shengxue Luo, Peng Zou, Chaolan Liang, Cong Wang, Jinfeng Li, et al. (+5)
15 [GO] 2022―Apr―29 Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2 Specific T cell therapy products Jessica Durkee-Shock, Christopher A. Lazarski, Mariah A. Jensen-Wachspress, Anqing Zhang, Aran Son, Vaishnavi V. Kankate, et al. (+8)
16 [GO] 2022―Mrz―24 Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models Giuseppe Palladino, Cheng Chang, Changkeun Lee, Nedzad Music, Ivna De Souza, Jonathan Nolasco, et al. (+5)
17 [GO] 2022―Mrz―16 Biodistribution and Environmental Safety of a Live-attenuated YF17D-vectored SARS-CoV-2 Vaccine Candidate Li-Hsin Li, Laurens Liesenborghs, Lanjiao Wang, Marleen Lox, Michael Bright Yakass, Sander Jansen, et al. (+7)
18 [GO] 2022―Mrz―09 Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles Ario de Marco, Lucio Barile
19 [GO] 2022―Feb―27 Tacrolimus-resistant SARS-CoV-2-specific T-cell products to prevent and treat severe COVID-19 in immunosuppressed patients Lena Peter, Désirée Jacqueline Wendering, Stephan Schlickeiser, Henrike Hoffmann, Rebecca Noster, Dimitrios Laurin Wagner, et al. (+14)
20 [GO] 2022―Feb―02 Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2 Tristan A. Scott, Aroon Supramaniam, Adi Idris, Angelo A. Cardoso, Surya Shrivastava, Gabrielle Kelly, et al. (+5)
21 [GO] 2021―Okt―19 Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues Anita Badbaran, Reiner K. Mailer, Christine Dahlke, Jannis Woens, Anahita Fathi, Sibylle C. Mellinghoff, et al. (+4)
22 [GO] 2021―Aug―26 Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques Hongbo Chen, Zhongping Xie, Runxiang Long, Shengtao Fan, Heng Li, Zhanlong He, et al. (+49)
23 [GO] 2021―Mai―14 Engineering mesenchymal stromal cells with neutralizing and anti-inflammatory capability against SARS-CoV-2 infection Xiaoqing Zhang, Ping Han, Haiyong Wang, Yanqin Xu, Fanlin Li, Min Li, et al. (+8)
24 [GO] 2021―Mrz―11 In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2 Magnus A.G. Hoffmann, Collin Kieffer, Pamela J. Bjorkman
25 [GO] 2020―Dez―25 Comprehensive and systemic optimization for improving the yield of SARS-COV-2 spike pseudotyped virus Xinping Fu, Lihua Tao, Xiaoliu Zhang
26 [GO] 2020―Nov―12 Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Bushra Mdkhana, Saba Al Heialy, Habiba S. Alsafar, Rifat Hamoudi, et al. (+2)
27 [GO] 2020―Jun―25 The two faces of ACE2: The Role of ACE2 receptor and its polymorphisms in hypertension and COVID-19 Mira Bosso, Thangavel Alphonse Thanaraj, Mohamed Abu-Farha, Muath Alanbaei, Jehad Abubaker, Fahd Al-Mulla
28 [GO] 2020―Jun―24 Characteristics and Therapeutic Options of the Coronavirus Disease 2019 Boxuan Huang, Rongsong Ling, Yifan Cheng, Jieqi Wen, Yarong Dai, Wenjie Huang, et al. (+4)
29 [GO] 2020―Mai―22 Expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 in the lung airways is lower in children compared to adults and increases due to smoking and COPD Narjes Saheb Sharif-Askari, Fatemeh Saheb Sharif-Askari, Mashael Alabed, Mohamed-Hani Temsah, Saba Alheialy, Qutayba Hamid, Rabih Halwani
 [1] 

29 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec